March 17, 2021
Getting patients with acute ischemic stroke treated more rapidly either through the use of a mobile stroke unit or by taking them directly to the angiography suite increases the number of patients who receive proven therapies and improves clinical outcomes, show two trials presented during the virtual International Stroke Conference 2021 this week.
In the BEST-MSU study, patients initially treated in a mobile stroke unit equipped with mobile CT and able to administer tissue plasminogen activator (tPA) were more likely to receive it within the first “golden hour” and had better functional outcomes at 90 days compared with patients taken to the hospital in a standard ambulance, James Grotta, MD (Memorial Hermann – Texas Medical Center, Houston), reported.
(UPDATED) There is no difference in in-hospital outcomes or longer-term mortality between patients undergoing revascularization with either a durable-polymer DES or newer technology with a bioabsorbable polymer, according to the results of a retrospective analysis.
Among more than 53,000 consecutive PCIs performed between 2015 and 2018 in Michigan, researchers found there was no difference in the risk of in-hospital mortality or stent thrombosis between patients who received the bioabsorbable-polymer everolimus-eluting stent (Synergy; Boston Scientific) and those treated with either the durable-polymer everolimus-eluting stent (Xience; Abbott Vascular) or the durable-polymer zotarolimus-eluting stent (Resolute; Medtronic).
Importantly, at 2 years, there was also no significant difference in the risk of death between the stent groups.
E-Mail
NEW YORK, NY (Feb. 18, 2021) A new study from Columbia University Vagelos College of Physicians and Surgeons has found that suicide mortality can be reduced by a Federally coordinated approach employing scientifically proven options.
Columbia researchers J. John Mann, MD, Christina A. Michel, MA, and Randy P. Auerbach, PhD, conducted a systematic review, determining which suicide prevention strategies work and are scalable to national levels.
The study, Improving Suicide Prevention Through Evidence-Based
Strategies: A Systematic Review, was published online in the
American Journal of Psychiatry.
The researchers found that screening school children or the general population for those at risk for suicide the tenth leading cause of death in the U.S. with 48,344 suicide deaths in 2018 have generally not reduced suicide rates.
First report on mass shootings from Columbia University database eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
By American Heart Association News
HealthDay Reporter
FRIDAY, Jan. 15, 2021 (American Heart Association News) Experts have a simple answer for heart and stroke patients questioning whether they need a COVID-19 vaccination. That answer: yes. People with all kinds of cardiovascular risk factors and disease should definitely get vaccinated to protect themselves and their families from COVID-19, said Dr. Mitchell Elkind, a professor of neurology and epidemiology at NewYork-Presbyterian Hospital/Columbia University Irving Medical Center in New York City.
The Food and Drug Administration-approved vaccines pose no special problems for such patients, said Elkind, who also is president of the American Heart Association. The AHA issued a statement Friday calling for people with cardiovascular risk factors, heart disease or a history of heart attack or stroke to get vaccinated as soon as possible. Getting vaccinated is especially important for them, Elkind